Rola bakterii Streptococcus mutans w patogenezie prochnicy

• Autorzy: Zandecka-Dziubak J , Tomaszewska M. , Lipinski D. , Mrozikiewicz P.M.
• Języki publikacji: PL

Abstrakty

PL

W Polsce i na świecie próchnica została uznana za chorobę społeczną. Badania z udziałem ludzi potwierdziły, że za inicjację i postępowanie tej choroby odpowiedzialne są bakterie Streptococcus mutans. Wiele analiz wskazuje na kluczową rolę specyficznych białek S. mutans (antygen 1/11, glukozylotrasferaza GTF, białka GBP) w patogenezie próchnicy. Badania dowiodły, że antygeny te bądź ich fragmenty mogą być efektywnymi immunogenami przeciwko próchnicy.

EN

Dental caries was recognized as a social problem in Poland and in the world. Streptoccocus mutans and Streptococcus sobrinus were strongly implicated as the causative organisms of human and animal dental caries. Specific proteins of S. mutans (antigen l/ll and glucosyltransferase GTF, GBP-proteins) have been implicated as the virulence factors in the molecular pathogenesis of dental caries. A lot of investigations indicated that the antigens or its fragments can be effective immunogenes against caries.

Słowa kluczowe

PL

glukozylotransferazy; patogeneza; prochnica; bakterie; immunizacja; Streptococcus mutans

• Wydawca: -
• Czasopismo: Herba Polonica
• Rocznik: 2004
• Tom: 50
• Numer: 2
• Opis fizyczny: s.94-110,tab.,bibliogr.

Twórcy

autor

Zandecka-Dziubak J

• Instytut Roslin i Przetworow Zielarskich, ul.Libelta 27, 61-707 Poznan

autor

Tomaszewska M.

autor

Lipinski D.

autor

Mrozikiewicz P.M.

Bibliografia

• 1. Hamada S, Slade HM, Biology, immunology and cariogenicity of Streptococcus mutans. Microbiol Rev 1980;44:331-384.
• 2. Loesche WJ, Role of Streptococcus mutans in human dental decay. Microbiol Rev 1986; 50:353- 380.
• 3. Szymańska J, Fetkowska-Mielnik K, Aspects of dental health in adult rural population in Poland. Ann Agric Environ Med 1998; 5:103-108.
• 4. National Institute of Health 2000, U.S. Department of Health and Human Services. Oral Health in America: A Report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, National Institute of Dental and Craniofacial Research .
• 5. Marthaler TM, Changes in dental caries 1953-2003. Caries Res 2004; 38(3):173-81.
• 6. Jańczuk Z, Stan narządu żucia polskiej populacji. Nowa Stomatologia 1997; 3:46-49.
• 7. Lichota D, Evaluation of oral health in the adult population from ages 35-44 in Poland. Ann Acad Med Stetin 1998; 44:263-83.
• 8. Popowski W, Wieczorek P, Plokwicz P, Wychowański P, Stan uzębienia i potrzeby lecznicze osób w wieku 35-44 lat zamieszkałych w regionie warszawskim. Nowa Stomatologia 2001; 15(1): 10-15.
• 9. Loesche WJ, Rowan J, Straffon LH, Loos PJ, Association of Streptococcus mutans with human tooth decay. Infect Immun 1975; 11:1252-1260.
• 10. Loesche WJ, Straffon LH, Longitudinal investigation of the role of Streptococcus mutans in human fissure decay. Infect Immun 1979; 26:498-507.
• 11. Marsh P, Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res 1994; 8:263-271.
• 12. Marcotte H, Lavoie MC, Oral microbial ecology and the role of salivary immunoglobulin A Microbiology and Molecular Biology Rewievsl998; 62(1 ):71-109.
• 13. Van HouteJ, Role of micro-organisms in caries etiology. J Dent Res 1994; 73:672-681.
• 14. Koga T, Oho T, Shimazaki Y, Nakano Y, Immunization against dental caries. Vaccine 2002; 20(16):2027-44.
• 15. Denepitiya L, Schiött CR, Streptococcus mutans - like bacteria from human dental plaque in a Sri Lanka Ceylon) population. ScandJ Den Res 1980; 88:40-45.
• 16. Bratthal D, Carlsson P, Clinical microbiology of saliva. In Human Saliva: Clinical Chemistry and Microbiology. Ed J Tenovuo, Boca Raton, Florida: CRC Press 1989.
• 17. Bratthal D, Dental caries. Markers of high and low risk groups and individuals: The Global Epidemiology of Mutans Streptococci. Ed N W Johnson Cambrige University Press 1991.
• 18. Yu H, Nakano Y, Yamashita Y, Ohio T, Koga T, Effects of antibodies against cell surface protein antigen PAc - Glucozyltransferase fusion proteins on glucan synthesis and cell adhesion of Streptococcus mutans. Infect Immun 1997; 65(6): 2292-2298.
• 19. Caufield PW, Walker TM, Isolation of a glucan binding domain of glucosyltransferase (1,6-alpha- glucan synthase) from Streptococcus sobrinus. j Clin Microbiol 1989; 27:274-278.
• 20. Marsh P, Martin M, Oral microbiology, 3rd ed. Chapman & Hall, Ltd., London, United Kingdom 1992.
• 21. Nyvad B, Microbial colonization of human tooth surfaces. Acta Pathol Microbiol Immunol Scand 1993; 101:7-45.
• 22. Hajishengallis G, Russell MW, Michalek SM, Comparison of an adherence domain and a structural region of Streptococcus mutans antigen 1/11 in protective immunity against dental caries in rats after intranasal immunization. Infect Immun 1998; 66:1740-1743.
• 23. Jenkinson HF, Cell surface protein receptors in oral streptococci. FEMS Microbiol Lett 1994; 121 (2): 133-40.
• 24. Haas W, Banas JA, Ligand-binding properties of the carboxyl-terminal repeat domain of Streptococcus mutans glucan-binding protein. AJ Bacteriol 2000; 182(3):728-33.
• 25. Russell MW, Lehner T, Characterization of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c. Arch Oral Biol 1978; 23:7-17.
• 26. Russell RRB, Wall-associated protein antigens of Streptococcus mutans. J Gen Microbiol 1979; 114:109-115.
• 27. Forester H, Hunter N, Knox KW, Characteristic of high molecular weight extracellular protein of Streptococcus mutans. J Gen Microbiol 1983; 129:2779-2788.
• 28. Okahashi NC, Sasakawa C, Yoshikawa M, Hamada S, Koga T, Molecular characterization of a surface protein antigen gene from serotype c Streptococcus mutans, implicated in dental caries. Mol Microbiol 1989; 3:673-678.
• 29. Russell MW, Immunization against dental caries. Curr Opin Den. 1992; 2:72-80.
• 30. Ackermans SF, Klein JP, Ogier JA, Bazin H, Cromont F, Franck RM, Purification and characterization of a saliva interacting cell wall protein from Streptococcus mutans serotype f by using monoclonal antibody immunoaffinity chromatography. BiochemJ 1985; 228:211-217.
• 31. Ogier JA, Scholler M, Leproivre Y, Pini A, Sommer P, Klein PJ, Complete nucleotide sequence of the sr gene from Streptococcus mutans OMZ175. FEMS Microbiol Lett 1990; 68:223-228.
• 32. Demuth DR, Lammey MS, Huck M, Lally ET, Malamud D, Comparison of Streptococcus mutans and Streptococcus sanguis receptors for human salivary agglutinin. Microb Pathog 1990; 9:199- 211.
• 33. Bowen WH, Schilling K, Role of a cell surface-associated protein in adherence and dental caries. Infect. Immun. 1991; 59:4606-4609.
• 34. Taubman MA, Holmberg CJ, Smith DJ, Immunization of rats with synthetic peptide constructs from the glucan-binding or catalytic region of mutans streptococcal glucosyltransferase protect against dental caries. Infect Immun 1995; 63(8):3088-3093.
• 35. Taubman MA, Smith DJ, Holmberg CJ, Eastcott J, Coimmunization with complementary glucosyltransferase peptides results in enhanced immunogenicity and protection against dental caries. Infect Immun 2000; 68:2698-2703.
• 36. Okahashi NC, Takahashi I, Nakai M, Senpuku H, Nisizawa T, Koga T, Identification of antigenic epitopes in an alanine - rich repeating region of a surface protein antigen of Streptococcus mutans. Infect Immun 1993; 61(4):1301-1306.
• 37. Jenkinson HF, Demuth DR, Structure, function and immunogenicity of streptococcal antigen 1/11 polypeptides. Mol Microbiol 1997; 23:183-190 .
• 38. Lee SF, Progulske-Fox A, Bleiweis AS, Molecular cloning and expression of a Streptococcus sobrinus major surface protein antigen, PI (l/II), in Escherichia coli. Infect Immun 1988; 56:2114-2119.
• 39. Okahashi NC, Sasakawa C, Yoshikawa M, Hamada S, Koga T, Cloning of a surface protein antigen gene from serotype c Streptococcus mutans. Mol Microbiol 1989; 3:221-228
• 40. Kelly C, Evans P, Bergmeier L, Lee SF, Progulske-Fox A, Harris AC et al, Sequence analysis of the cloned streptococcal cell surface antigen I/II. FEBS Lett 1989; 258:127-132.
• 41. Brady LJ, Piacentini DA, Crowley PJ, Bleiweis AS, Identification of monoclonal antibody-binding domains within antigen P1 of Streptococcus mutans and cross-reactivity with related surface antigens of oral streptococci. Infect Immun 1991; 59:4425-4435.
• 42. Lehner T, The relationship between human helper and suppressor factors to a streptococcal protein antigen. J Immunol 1982; 129:1936-1940.
• 43. Lehner T, Cadwell J, Avery J, Sequential development of helper and suppressor functions, antibody titers and functional avidities to a streptococcal antigen in rhesus monkeys. Eur J Immunol 1984; 14:814-819.
• 44. McBride BC, Song M, Krasse B, OlssonJ, Biochemical and immunological differences between hydrophobic and hydropholic strains of Streptococcus mutans. Infect Immun 1984; 44:68-75.
• 45. Lee SF, Progulske-Fox A, Erdos GW, Ayakawa GA, Crowley PJ, Bleiweis AJ, Construction and characterization of isogenic mutants of Streptococcus mutans deficient in major surface protein antigen PI (1/11). Infect Immun 1989; 57:3306-3313.
• 46. Ohta H, Okahaski N, Takahashi T, Hamada S, Koga T, Characterization of a cell-surface protein antigen of hydrophilic Streptococcus mutans strain GS-5. J Gen Microbio 1989; 135:981-988.
• 47. Koga T, Okahashi N, Takahashi I, Kanamoto T, Asakawa H, Iwaki M, Surface hydrophobicity, adherence, and aggregation of cell surface protein antigen mutants of Streptococcus mutans serotype c. Infect Immun 1990; 58:289-296.
• 48. Russell MW, Rahemmtulla BM-B, Interaction between surface protein antigens of Streptococcus mutans and human salivary components. Oral Microbiol Immunol 1989; 4:106-111.
• 49. Koga T, Asakawa H, Okahashi N, Takahashi I, Effect of subculturing on expression of a cell- surface protein antigen by Streptococcus mutans.) Gen Microbiol 1989; 135:3199-3207.
• 50. Kolenbrander PE, Ganeshkumar N, Classeis Fj, Coaggregation specific adherence among human oral plaque bacteria. FASEBJ 1993; 7:406-413.
• 51. Kuramitsu HK, Virulence factors of mutans streptococci: role of molecular genetics. Crit Rev Oral Biol Med 1993; 4:159-176.
• 52. Aoki HT, Shiroza M, Hayakawa S, Sato S, Kuramitsu HK, Cloning of a Streptococcus mutans glucosyltransferaze gene coding for insoluble glucan synthesis. Infect Immunn 1986; 53:587-594.
• 53. Shiroza T, Ueda S, Kuramitsu HK, Sequence analysis of the gtfB gene from Streptococcus mutans.
• J Bacterid 1987; 69:4263-4270.
• 54. Ueda S, Shiroza T, Kuramitsu HK, Sequence analysis of the gtfC gene from Streptococcus mutans GS-5. Gene 1988; 69:101-109.
• 55. Hanada N, Kuramitsu HK, Isolation and characterization of the Streptococcus mutans gtfD gene, coding for primer-dependend soluble glucan synthesis. Infect Immun 1989; 57:1999-2105.
• 56. Honda O, Kato C, Kuramitsu HK, Nucleotide sequence of the Streptococcus mutans gtfD gene encoding the glokosyltransferase-S enzyme. J Gen Microbiol 1990; 136:2099-2105.
• 57. Fukushima K, lkeda T, Kuramitsu HK, Expression of Streptococcus sobrinus gtf genes in Streptococcus milleri. Infect Immun 1992; 60:2815-2822.
• 58. Fujiwara TM, Tamesada M, Bian Z, Kawabata S, Kimura S, Hamada S, Deletion and reintroduction of glukosyltransferase genes of Streptococcus mutans and role of their gene products in sucrose dependent cellural adherence. Microb Pathol 1996; 20:225-233.
• 59. Yamashita YW, Bowen WH, Burne RA, Kuramitsu HK, Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen-free rat model. Infect Immun 1993; 61:3811-3817.
• 60. Smith DJ, van Houte J, Kent R, Taubman MA, Effect of antibody in gingival crevicular fluid on early colonization of exposed root surfaces by mutans streptococci. Oral Microbiol Immunol 1994; 9:65-69.
• 61. Smith DJ, Shoushtari B, Heschel RL, King WF, Taubman MA, Immunogenicity and protective immunity induced by synthetic peptides associated with a catalytic subdomain of mutans group streptococcal glucosyltransferase. Infect Immun 1997; 65:4424-4430.
• 62. Mooser G, Hefta SA, Paxton RJ, ShivelyJE, Lee TD, Isolation and sequence of an active-site peptide containing a catalytic aspartic acid from two Streptococcus sobrinus a-glucosyltransferases.
• J Biol Chem 1991; 266:8916-8922.
• 63. ChiaJS, Lin SW, Hsu TY, Chen JY, Kwan HW, Yang CS, Analysis of a DNA polymorphic region in the gtfB and gtfC genes of Streptococcus mutans strain. Infect Immun 1993; 61:1563-1566.
• 64. Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR, Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 2002; 4165-4176.
• 65. ChiaJS, Lin SW, Yang CS, Chen JY, Antigenicity of a synthetic peptide from glukosylotransferases of Streptococcus mutans in humans. Infect Immun 1997; 65:1126-1130.
• 66. Tsumori H, Minami T, Kuramitsu HK, Identification of essential amino acids in the Streptococcus mutans glukosyltransferases. J Bacteriol 1997; 1:3391-3396.
• 67. Smith DJ, Taubman MA, Holmberg CF, King WF, Ail-Salaam P, Antigenicity and immunogenicity of a synthetic peptide derived from a glucan binding domain of mutans streptococcal glucosyltransferase. Infect Immun 1993; 61:2899-2905.
• 68. Mooser G, Wong C, Isolation of glucan-binding domain of glucosyltransferase (1,6-a- glucosyltransferase) from Streptococcus sobrinus. Infect Immun 1988; 56:880-884.
• 69. Lis MT, Shiroza T, Kuramitsu HK, Role of the C-terminal direct repeating units of the Streptococcus mutans glukosyltransferase-S in glucan binding. Applied Environ Microbiol 1995; 61:2040-2042.
• 70. ChiaJS, Yang CS, Chen JY, Functional analyses of conserved region in glucosylotransferases of Streptococcus mutans. Infect Immun 1998; 66(10):4797-4803.
• 71. Banas JA, Russell RRB, Feretti JJ, Sequence analysis of the gene for the glucan-binding protein of Streptococcus mutans. Ingbritt Infect Immun 1990; 58(3): 667-73.
• 72. Smith DJ, Akita H, King WF, Taubman MA, Purification and antigenicity of a novel glucan-binding protein of Streptococcus mutans. Infect Immun 1994 Jun; 62(6):2545-52.
• 73. Sato Y, Yamamoto Y, Kizaki H, Cloning and sequence analysis of the gbpC gene encoding a novel glucan-binding protein of Streptococcus mutans. Infect Immun 1997; 65(2):668-75.
• 74. Landale EC, McCabe MM, Characterization by affinity electrophoresis of an alpha-1,6-glucan- binding protein from Streptococcus sobrinus. Infect Immun 1987; 55( 12):3011-3016.
• 75. Wu-Yuan CD, Gill RE, An 87-kilodalton glucan-binding protein of Streptococcus sobrinus B13. Infect Immun 1992; 60:5291-5293.
• 76. Ma Y, Lassiter MO, Banas JA, Galperin MY, Taylor KG, Doyle RJ, Multiple glucan-binding proteins of Streptococcus sobrinus. J Bacteriol 1996; 178:1572-1577.
• 77. Smith DJ, King WF, Wu CD, Shen BI, Taubman MA, Structural and antigenic characteristic of Streptococcus sobrinus glucan binding proteins. Infect Immun 1998; 66:5565-5569.
• 78. Jin S, Duncan MJ, Taubman MA, Smith DJ, Cloning of the gbpB gene from Streptococcus mutans.
• J Dent Res 2000; 79:224.
• 79. Mattos-Graner RO, Jin S, King W F, Chen T, Smith DJ, Duncan MJ, Cloning of the Streptococcus mutans gene encoding glucan binding protein B and analysis of genetic diversity and protein production in clinical isolates. Infect Immun 2001; 69( 11 ):6931-41.
• 80. Schubert K, Bichlmaier AM, Mager E, Wolff K, Ruhland G, Fiedler F P45, an extracellular 45 kDa protein of Listeria monocytogenes with similarity to protein p60 and exhibiting peptidoglycan lytic activity. Arch Microbiol 2000; 173(1 ):21 -8.
• 81. Reinscheid DJ, Gottschalk B, Schubert A, Eikmanns BJ, Chhatwal GS, Identification and molecular analysis of PcsB, a protein required for cell wall separation of group B streptococcus. J Bacteriol 2001; 183(4); 1175-83.
• 82. Rundegren J, Calcium-dependent salivary agglutinin with reactivity to various oral bacterial species. Infect Immun 1986; 53:173-178.
• 83. Tabak LA, Structure and function of human salivary mucins. Crit Rev Oral Biol Med 1990; 1:229- 234.
• 84. Słomiany BL, Murty VLN, Piotrowski J, Słomiany A, Salivary mucins in oral mucosal defence. Ge Pharmacol 1996; 27:761-771.
• 85. Pruitt KM, Rahemtulla B, Rahemtulla F, Russell MW, Innate humoral factors, ln P.L. Ograj. Mestecky, M.E. Lamm, W. Strober, J. Bienenstock, J.R. McGhee (ed.), Mucosal immunology. Academic Press, San Diego, 2nd ed Calif 1999; 65-88.
• 86. Tabak LA, Levine MJ, Mandel ID, Ellison SA, Role of salivary mucins in the protection of the oral cavity. J Oral Pathol 1982; 11(1):1-17.
• 87. Donoghue HD, Hudson DE, Perrons CJ, Effect of the lactoperoxidase system on streptococcal acid production and growth. J Dent Res 1987; 66(2):616-8.
• 88. Kerr MA, The structure and function of human IgA. Biochem J 1990; 271(2):285-96.
• 89. Smith DJ, Taubman MA, Ontogeny of immunity to oral microbiota in humans. Crit Rev Oral Biol Med 1992; 3:109-133.
• 90. Caufield P, Cutter GR, Dasanayake AP, Initial acquisition of mutans streptococci by infants: evidence for a discrete window of infectivity. J Dent Res 1993; 72:37-45.
• 91. Cole MF, Bryan S, Evans MK, Pearce CL, Sheridan MJ, Sura PA et al, Humoral immunity to commensal oral bacteria in human infants: salivary secretory immunoglobulin A antibodies reactive with Streptococcus mitis biovar 1, Streptococcus oralis, Streptococcus mutans, and Streptococcus faecalis during the first two years of life. Infect Immun 1999; 67(4): 1878-1886.
• 92. Russell RRB, Beighton D, Cohen B, Immunization of monkeys (Maccaca fascicularis) with antigens purified from Streptococcus mutans. Br Dent J 1982; 152:81-84.
• 93. LehnerT, Caldwell J, Smith R, Local passive immunization by monoclonal antibodies against streptoccocal antigen l/II in the prevention of dental caries. Infect Immun 1985; 50: 796-799.
• 94. Czerkinsky C, Russell MW, Lyeke N, Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect Immun 1989; 57:1072-1077.
• 95. Michalek SM, Use of liposomes for the induction of mucosal immunity. Vaccine Res 1992; 1:241- 247
• 96. KatzJ, Harmon CC, Buckner GP, Richardson GJ, Russell MW, Michalek SM, Protective salivary immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen l/ll coupled to the B subunit of cholera toxin. Infect Immun 1993; 61:1964-1971.
• 97. Kelly C, Todryk S, Kendal HL, Munro GH, Lehner T, T-cell, adhesion, and B-cell epitopes of the cell surface Streptococcus mutans protein antigen 1/11. Infect Immun 1995; 63:3649-3658.
• 98. Ogasawara K, Naruse H, Itoh Y, Gotohda T, Arikawa J, Kida H et al, A strategy for making synthetic peptide vaccines. Pro Natl Acod Sei USA 1992; 89:8995-8999.
• 99. Calvo-CalleJ.M, de Oliveira GA, Clavijo P, Maracie M, Tam JP, Lu YA et al, Immunogenicity of multiple peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasmodium falciparum.} Immun 1993; 150:1403-1412.
• 100. Senpuku H, Kato H, Todoroki M, Hanada N, Nisizawa T, Interaction of lysozyme with a surface protein antigen of Streptococcus mutans. FEMS Microbiol Lett 1996; 139:195-201.
• 101. Senpuku H, Kato H, Takeuchi H, Noda A, Nisizawa T, Identification of core B cell epitope in the synthetic peptide inducing cross-inhibiting antibodies to a surface protein antigen of Streptococcus mutans. Immunological Investigations 1997; 26(5-7):531 -548.
• 102. Lehner T, Challacombe SJ, Caldwell J, An immunological investigation into the prevention of caries in deciduous teeth of rhesus monkey. Arch Oral Biol 1975; 20:305-310.
• 103. Lehner T, Russell MW, Caldwell J, Smith R, Immunization with a purified protein from Streptococcus mutans against dental caries in rhesus monkeys. Lancet 1981; 1:995-996.
• 104. Smith R, Lehner T, Beverley PCL, Characterization of monoclonal antibodies to Streptococcus mutans antigenic determinants 1/11,1, II, and III and their serotype specificities. Infect Immun 1984; 46:168-175.
• 105. Ma JK-C, Smith R, Lehner T, Use of monoclonal antibodies in local passive immunization to prevent colonization of human teeth by Streptococcus mutans. Infect lmmunl987; 55:1274-1278.
• 106. Ma JK-C, Hunjan M, Smith R, Lehner T, Specificity of monoclonal antibodies in local passive immunization against Streptococcus mutans. Clin Ex. Immunol 1989; 77:331-337.
• 107. Hajishengallis G, Hollingshead SK, Koga T, Russell MW, Inhibition of Streptococcus mutans adherence to saliva-coated hydroxyapatite by human secretory immunoglobulin A (S-lgA) antibodies to cell surface protein antigen 1/11: Reversal by IgAl protease cleavage. Infect Immun 1992; 60(12):5057-5064.
• 108. Bowen WH, Cohen B, Cole MF, Colman G, Immunization against dental caries. Br DentJ 1975; 139:45-58.
• 109. Jackson S, MesteckyJ, Childers NK, Michalek SM, Liposomes containing anti-idiotypic antibodies: an oral vaccine to induce protective secretory immune responses specific for pathogens of mucosal surfaces. Infect Immun 1990; 58:1932-1936.
• 110. Russell MW, Wu H-Y, Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen 1/11 of Streptococcus mutans coupled to the cholera toxin B subunit. Infect Immun 1991; 59:4061-4070.
• 111. Wu HY, Russell MW, Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun 1993; 61(l):3l4-322.
• 112. Mestecky J, McGee JR, Arnold RR, Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest 1978; 61:731-737
• 113. Michalek SM, Gregory RL, Scholler-Guinard M, Kimura S, MesteckyJ, Curtis R et al, Immunity to dental caries: induction of protective salivary IgA antibodies to Streptococcus mutans. 1985; 99- 105 In J. P. Revillard, C. Voisin, and N. Wierzbicki (ed.) Mucosal immunity IgA and polymorphonuclear neutrophils. Fondation Franco-Allemande, Suresnes Cedex, France.
• 114. Smith DJ, King WF, Barnes LA, Trantolo D, Wise D, Taubman MA, Facilitated intranasal induction of mucosal and systemic immunity to mutans streptococcal glukosyltransferase peptide vaccines Infect Immun 2001; 69(8):4767-4773.
• 115. Redman TK, Harmon CC, Lallone RL, Michalek SM, Oral immunization with recombinant Salmonella typhimurium expressing surface antigen A of Streptococcus sobrinus: dose response and induction of protective humoral responses in rats. Infect Immun 1995; 63:2004-2011.
• 116. Evans RT, Emmings FG, Genco RJ, Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in irus monkeys (Macaca fascicularis). Infect Immun 1975; 12:293-302.
• 117. Linzer R, Evans RT, Emmings FG, Genco RJ, Use of combined immunization routes in induction of a salivary immunoglobulin A response to Streptococcus mutans in Macaca fascicularis monkeys. Infect Immun 1981;31:345-351.
• 118. Walker J, Antibody responses of monkeys to oral and local immunization with Streptococcus mutans. Infect Immun 1981; 31:61-70.
• 119. Eggert FM, Gurner BW, Reaction of human colostral and early milk antibodies with oral streptococci. Infect Immun 1984; 44:660-664.
• 120. Childers NK, Tong G, Michell S, Kirk K, Russell MW, A controlled clinical study of the effect of nasal immunization with a Streptococcus mutans antigen alone or incorporated into liposomes on induction of immune responses. Infect Immun 1999; 67(2):618-623.
• 121. Zhang P, Jespersgaard C, Lamberty-Mallory L, KatzJ, Huang Y, Hajishengallis G et al, Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Infect Immun 2002; 70(12):6779-6787A.
• 122. Mitoma M, Oho T, Michibata N, Okano K, Nakano Y, Fukuyama M et al, Passive immunization with bovine milk containing antibodies to a cell surface protein antigen-glucosyltransferase fusion protein protects rats against dental caries, Infect Immun 2002; 70(5):2721-2724.
• 123. Smith DJ, Taubman MA, Experimental immunization of rats with a Streptococcus mutans 59- kilodalton glucan-binding protein protects against dental caries. Infect Immun 1996; 64(8):3069- 73.
• 124. Smith DJ, Heschel RL, Melvin J, King WF, Pereira MBB, Taubman MA, Streptococcus mutans glucan binding proteins as dental caries vaccines, 1997; 367-377. In Husband AJ, Beagley KW, Clancy RL, Collins AM, Cripps AW, Emery DL (ed.), Mucosal solutions: advances in mucosal immunology, vol. 2. University of Sydney Press, Sydney, Australia.
• 125. Smith DJ, King WF, Godiska R, Passive transfer of immunoglobulin Y antibody to Streptococcus mutans glucan-binding protein B can confer protection against experimental dental caries. Infect Immun 2001; 69(5):3135-3142.
• 126. Russell MW, MesteckyJ, Potential for immunological intervention against dental caries. J Biol Buccale 1986; 14:159-175.
• 127. Ma JK-C, Hunjan M, Smith R, Kelly C, Lehner T, An investigation into the mechanism of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect Immun 1990; 58:3407-3414
• 128. Filler SJ, Gregory RL, Michalek SM, KatzJ, McGheeJR, Effect of immune bovine milk on Streptococcus mutans in human dental plaque. Arch Oral Biol 1991; 36:41-47.
• 129. Czerkinsky C, Prince SJ, Michalek SM, IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans. Proc Natl Acad Sei USA 1987; 84:2449-2453.
• 130. Gregory RL, Filler SJ, Protective secretory immunoglobulin A antibodies in humans following oral immunization with Streptococcus mutans. Inrect Immun 1987; 55:2409-2415.
• 131. Smith DJ, Taubman MA, Effect of local deposition of antigen on salivary immune responses and reaccumulation of mutans streptococci. J Clin Immunol 1990; 10:273-281.
• 132. Challacombe SJ, LehnerT, Salivary antibody responses in rhesus monkeys immunized with Streptococcus mutans by the oral, submucosal, or subcutaneous routes. Arch Oral Bio 1980; 24:917- 925.
• 133. Michalek SM, Lackner AA, KatzJ, Russell MW, Eldridge JH, MesteckyJ et al, Oral immunization studies with Streptococcus mutans and influenzae vaccines in rhesus macaque monkeys. Adv Exp Med Biol 1995; 37IB: 1423-1429 .
• 134. Hajishengallis G, Michalek SM, Russell MW, Persistence of serum and salivary antibody responses after immunization with bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin. Infect Immun 1996; 64:665-667.
• 135. Hajishengallis G, Hollingshead SK, Koga T, Russell MW, Mucosal immunization with a bacteria protein antigen genetically coupled to cholera toxin A2/B subunits. J Immunol 1995; 154:4322- 4332.
• 136. Farmakopea Polska, Salviae folium, VI, 2002; 891-892.
• 137. Escop Monographs Salviae officinalis folium Second Edition 2003:452-455.
• 138. Steinegger E, Pharmacognosie, 5th ed. Berlin-Heidelberg: Springer Verlag 1992:343-345.
• 139. Schwarz K, Ternes W, Antioxidative constituents of Rosmarinus officinalis and Salvia officinalis. Z Unters Forsch 1992; 195(2):99.
• 140. Góraj, Lis A, Najcenniejsze olejki. Olejki szałwii. Aromaterapia 1998; 4(14):5.
• 141. Lu Y, Foo LY, Rosmarinic acid derivatives from Salvia officinalis. Phytochemistry 1999; 51:91-4.
• 142. Jalsenjak V, Peljnjak S, Kustrak D, Microcapsules of sage oil: essential oils content and antimicrobial activity. Pharmazie 1987; 42:419-20.
• 143. Janssen AM, Antimicrobial activities of essential oils- a pharmacognostical study [Disseration], Leiden: Rijksuniversiteit te Leiden 1989:91-108.
• 144. Baricevic D, Sosa S, Della Loggia R, Tubaro A, Simonovska B, Krasna A el al, Topical antiinflamatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 2001; 75:125-32.
• 146. Van Dyke, Braswell L, Offenbacher S, Inhibition of gingivitis by topical application of ebselen and rosmarinic acid. Agent Actions 1986; 19:376-377.
• 147. Munro G, Ewans P, Todryk S, Buckett P, Kelly GC, Lehner T, A protein fragment of streptococcal cell surface antigen 1/11 which prevents adhesion of Streptococcus mutans. Infect Immun 1993; 61(11):4590-4598.
• 148. lwaki M, Okahashi T, Takahashi I, Oral immunization with recombinant Streptoccocus lactis carrying the Streptococcus mutans surface protein antigen gene. Infect Immun 1990; 58(9):2929-2934.
• 149. Jespersgaard C, Hajishengallis G, Greenway TE, Smith DJ, Russell MW, Michalek SM, Functional and immunogenic characterization of two cloned regions of Streptococcus mutans glucosyl- transferase. Infect Immun 1999; 67 (2): 810-815.
• 151. Horaud T, Delbos F, Viridans streptococci in infective endocarditis: species distribution and susceptibility to antibiotics. Eur Heart J 1984; 5:39-44 .
• 152. Chang SC, Luh KT, Deng LJ, Hsieh WC, Bacteriology of viridans streptococcal bactermia. Chin J Microbiol Immunol 1987; 20:311-318 .
• 153. Stinson MW, Adverse effect of Streptococcus mutans antigens on host tissues, In S. Hamada, S.M. Michalek, H. Kiyono, L. Menaker, andJ.R. McGhee (ed.), Molecular microbiology and immunology of Streptococcus mutans. Elsvier Science Publishers 1986:307-318, Amsterdam, The Netherlands.
• 154. Chia JS, Yeh CY, Chen JY, Identification of a fibronectin binding protein from Streptococcus mutans. Infect Immun 2000; 1864-1870.
• 155. Scheid WM, Pathogenesis and pathophysiology of infective endocarditis. 1984:1-32. In M.A. Sande, D. Kaye, and R.K. Root (ed.), Endocarditis. Churchill Livingstone, Ltd., New York, N.Y .